Movement disorders : official journal of the Movement Disorder Society

publication venue for

The Need for Staging System in Colony Stimulating Factor 1 Receptor-Related Disorder. 2026
ENLITE PD: A Randomized Clinical Trial of Light Therapy for Impaired Sleep in Parkinson's Disease.. 40. 2025
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Parkinson's Disease in Patients with Type 2 Diabetes: A Population-Based Cohort Study.. 39. 2024
Diagnostic Criteria for Primary Tic Disorders: Time for Reappraisal.. 39. 2024
Safety and Efficacy of IPX203 in Parkinson's Disease: The RISE-PD Open-Label Extension Study.. 39. 2023
Rehabilitating Cough Dysfunction in Parkinson's Disease: A Randomized Controlled Trial.. 38. 2022
mTOR Inhibition with Sirolimus in Multiple System Atrophy: A Randomized, Double-Blind, Placebo-Controlled Futility Trial and 1-Year Biomarker Longitudinal Analysis.. 37. 2022
Sensorimotor Cough Dysfunction Is Prevalent and Pervasive in Progressive Supranuclear Palsy.. 36. 2021
Corneal Confocal Microscopy Identifies Parkinson's Disease with More Rapid Motor Progression.. 36. 2021
Hypoxia Conditioning as a Promising Therapeutic Target in Parkinson's Disease?. 36. 2021
Quantitative Measurement of Metal Accumulation in Brain of Patients With Wilson's Disease.. 35. 2020
Huntington's disease in the United States: Variation by demographic and socioeconomic factors.. 34. 2019
Neurological adverse event profile of magnetic resonance imaging-guided focused ultrasound thalamotomy for essential tremor.. 33. 2018
Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features.. 33. 2017
Projection of the prevalence of Parkinson's disease in the coming decades: Revisited.. 33. 2017
The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort.. 31. 2016
Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings.. 31. 2015
Reproducibility of a Parkinsonism-related metabolic brain network in non-human primates: A descriptive pilot study with FDG PET.. 30. 2015
A voxel-based morphometry and diffusion tensor imaging analysis of asymptomatic Parkinson's disease-related G2019S LRRK2 mutation carriers.. 29. 2014
Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations.. 28. 2013
Fall risk and gait in Parkinson's disease: the role of the LRRK2 G2019S mutation.. 28. 2013
Clinical and posturographic correlates of falling in Parkinson's disease.. 28. 2013
Prospective cohort study of impulse control disorders in Parkinson's disease.. 28. 2013
Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome Study.. 27. 2012
Milestones in neuroimaging.. 26. 2011
Increased reaction time predicts visual learning deficits in Parkinson's disease.. 25. 2010
Imaging essential tremor.. 25. 2010
Mirror movements in patients with essential tremor.. 24. 2009
Deep brain stimulation effects on gait variability in Parkinson's disease.. 24. 2009
Older onset essential tremor: More rapid progression and more degenerative pathology.. 24. 2009
Daily energy expenditure, physical activity, and weight loss in Parkinson's disease patients.. 24. 2009
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.. 23. 2008
Cancer and blood concentrations of the comutagen harmane in essential tremor.. 23. 2008
Abnormal metabolic networks in atypical parkinsonism.. 23. 2008
Microstructural white matter changes in primary torsion dystonia.. 23. 2008
Identifying incident cases of parkinsonism among veterans using a tertiary medical center.. 22. 2007
Regional metabolic changes in parkinsonian patients with normal dopaminergic imaging.. 22. 2007
Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease.. 21. 2006
Blinded placebo crossover study of gabapentin in primary orthostatic tremor.. 21. 2006
Long-term effects of bilateral subthalamic nucleus stimulation on health-related quality of life in advanced Parkinson's disease.. 21. 2006
Anticholinesterase effect on motor kinematic measures and brain activation in Parkinson's disease.. 21. 2006
Movement disorders fellowship training program at Columbia University Medical Center in 2001-2002.. 21. 2006
Proxy reports in Parkinson's disease: caregiver and patient self-reports of quality of life and physical activity.. 20. 2005
Gabapentin can improve postural stability and quality of life in primary orthostatic tremor.. 20. 2005
Cerebellar metabolic symmetry in essential tremor studied with 1H magnetic resonance spectroscopic imaging: implications for disease pathology.. 19. 2004
Reversible reorganisation of the motor cortical representation of the hand in cervical dystonia.. 18. 2003
Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism.. 17. 2002
Movement and reaction times and fine coordination tasks following pallidotomy.. 14. 1999
Positron emission tomographic studies in restless legs syndrome.. 14. 1999
Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET.. 13. 1998
Constipation in Parkinson's disease: objective assessment and response to psyllium.. 12. 1997
The characterization and outcome of stereotypical movements in nonautistic children.. 12. 1997
The audiogenic startle response in Tourette's syndrome.. 10. 1995
Bismuth subsalicylate toxicity as a cause of prolonged encephalopathy with myoclonus.. 10. 1995
Gastrointestinal symptoms in Parkinson disease: 18-month follow-up study.. 8. 1993
Gastrointestinal symptoms in Parkinson's disease.. 6. 1991
The metabolic anatomy of Parkinson's disease: complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies.. 5. 1990
Toward a Personalized Approach to Parkinson's Cell Therapy.. 35. 2020
Deep Brain Stimulation in Isolated Dystonia With a GNAL Mutation.. 34. 2018
Zolpidem improves tardive dyskinesia and akathisia.. 28. 2013
Bilateral globus pallidus internus deep brain stimulation after bilateral pallidotomy in a patient with generalized early-onset primary dystonia.. 28. 2013
Thalidomide induced acute worsening of Parkinson's disease.. 24. 2009
Case study of an unusual variant of restless leg syndrome.. 23. 2008
Retraction. Young-onset Parkinson's disease: hospital utilization and medical comorbidity in a nationwide survey.. 22. 2007
PINK1 homozygous W437X mutation in a patient with apparent dominant transmission of parkinsonism.. 21. 2006
Bilateral subthalamic nucleus deep brain stimulation in a patient with cervical dystonia and essential tremor.. 20. 2005
Woman with a 26-year history of parkinsonism, supranuclear ophthalmoplegia, and loss of postural reflexes.. 19. 2004
Bilateral subthalamic nucleus deep brain stimulation for advanced PD: correlation of intraoperative MER and postoperative MRI with neuropathological findings.. 18. 2003
Chemotherapy-induced parkinsonism responsive to levodopa: an underrecognized entity.. 18. 2003
Physiological assessment of paroxysmal dystonia secondary to subacute sclerosing panencephalitis.. 17. 2002
Emergence of complex, involuntary movements after gamma knife radiosurgery for essential tremor.. 16. 2001
Oculogyric-like crises in a 92-year-old woman with vascular Parkinsonism.. 16. 2001
Levodopa-induced dyskinesias in autopsy-proven cortical-basal ganglionic degeneration.. 15. 2000
Arm tremor secondary to Wilson's disease.. 13. 1998
Asymmetric predominantly ipsilateral blepharospasm and contralateral parkinsonism in an elderly patient with a right mesencephalic cyst.. 13. 1998
Imipenem-induced myoclonus.. 12. 1997
Rapid eye movement sleep behavior disorder preceding Parkinson's disease with therapeutic response to levodopa.. 11. 1996
Cricopharyngeal dysfunction in Parkinson's disease: role in dysphagia and response to myotomy.. 11. 1996
Lid opening apraxia is associated with medial frontal hypometabolism.. 10. 1995
Cortical activity preceding self-initiated and externally triggered voluntary movement.. 7. 1992
Adrenal to caudate transplantation--postmortem study.. 5. 1990
What is it? Case 1, 1990: progressive unilateral rigidity, bradykinesia, tremulousness, and apraxia, leading to fixed postural deformity of the involved limb.. 5. 1990
Inflammation in Parkinson's disease: cause or consequence?. 27. 2012
Assessing Digital Health Technologies for Outcome Measurement in Parkinson's Disease Drug Trials: A Systematic Review. 2025
Research Priorities on the Role of α-Synuclein in Parkinson's Disease Pathogenesis. 2024
Genotype-Phenotype Correlations for ATX-TBP (SCA17): MDSGene Systematic Review. 2022
Structural Biology of LRRK2 and its Interaction with Microtubules. 2021
A user's guide for α-synuclein biomarker studies in biological fluids: Perianalytical considerations. 2017
Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers. 2017
Effects of levodopa on regional cerebral metabolism and blood flow. 2014
Metabolic networks for assessment of therapy and diagnosis in Parkinson's disease. 2009
Gene transfer therapy for neurodegenerative disorders. 2007
Prospects for gene therapy in Parkinson's disease. 1996

VIVO Weill Cornell Medical College

Movement disorders : official journal of the Movement Disorder Society Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)